NCT06238921 2025-12-05Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain MetastasesH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Recruiting31 enrolled
NCT03175666 2025-02-21QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyImmunityBio, Inc.Phase 1/2 Withdrawn
NCT01217411 2024-11-19RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerNational Cancer Institute (NCI)Phase 1/2 Terminated5 enrolled 6 charts